Note: Ingredients listed on restricted chemical lists
EC/CAS
200-661-7/67-63-0
Name of the chemical
Propan-2-ol
Concentration
>=90-< 100%
EC/CAS
231-157-5/7440-47-3
Name of the chemical
Chromium; chromic acid and its salts
Concentration
>=1-<10
General Information
Version
6.5
Revision date
2022-07-24
Product name
QUILON H chromium complex solution QUILON H chromium complex solution
REACH No
This
Emergency telephone
+(47)-22591300, +(47)-21930678
Icons in SDS
Company Information
company name
Merck Life Science AS
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H225, H319, H336
Hazard statements
Code
Statements
H225
Highly Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Signal word
Danger Danger
Hazard statements
H225 Highly flammable liquid and vapor. H319 Causes serious eye irritation. H336 May cause drowsiness or dizziness. none
Precautionary statements
P210 Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. P233 Keep container tightly closed. P240 Ground and bond container and receiving equipment. P241 Use explosion-proof electrical/ ventilating/ lighting/ equipment. P242 Use non-sparking tools. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. none
Supplemental label elements
none Reduced Labeling (<= 125 ml) none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 Flammable liquids (Category 2), H225 Eye irritation (Category 2), H319 Specific target organ toxicity - single exposure (Category 3), Central nervous system, H336 For the full text of the H-Statements mentioned in this Section, see Section 16.
